A Metabolomic Investigation of Eugenol on Colorectal Cancer Cell Line HT-29 by Modifying the Expression of APC, p53, and KRAS Genes

<div><sup>1</sup>HNMR spectra of (a) the hydrophilic phase of eugenol-treated HT-29 cells (A1) and untreated controls (A2) and (b) the lipophilic phase of eugenol-treated HT-29 cells (B1) and untreated controls (B2).</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: A Metabolomic Investigation of Eugenol on Colorectal Cancer Cell Line HT-29 by Modifying the Expression of APC, p53, and KRAS Genes 